May 15 (Reuters)-
Cyfuse Biomedical K.K.
PARENT-ONLY FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
3 months ended 3 months ended Year to
Mar 31, 2025 Mar 31, 2024 Dec 31, 2025
LATEST YEAR-AGO LATEST
RESULTS RESULTS FORECAST
Sales 24 mln 10 mln 302 mln
(+125.3 pct) (+52.0 pct) (+455.8 pct)
Operating loss 240 mln loss 229 mln loss 1.22
Recurring loss 162 mln loss 223 mln loss 1.14
Net loss 162 mln loss 224 mln loss 1.14
EPS loss 19.90 yen loss 28.38 yen loss 139.64 yen
Ann Div NIL NIL
-Q2 div NIL NIL
-Q4 div NIL NIL
NOTE - Cyfuse Biomedical K.K..
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4892.T